Notice of Change to Receipt Dates on BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
(NOT-EB-18-005)
National Institute of Biomedical Imaging and Bioengineering
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Notice of Change in Key Dates for PAR-17-001 "Emerging Global Leader Award (K43)"
(NOT-TW-18-003)
John E. Fogarty International Center
National Cancer Institute
National Human Genome Research Institute
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Requests for Applications
Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required)
(RFA-AG-18-030)
National Institute on Aging
Application Receipt Date(s):
April 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM1 Clinical Trial Not Allowed)
(RFA-AI-18-001)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
June 28, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIAMS Skin Biology and Diseases Resource-based Centers (P30 Clinical Trial Not Allowed)
(RFA-AR-19-001)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s):
June 11, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed)
(RFA-ES-18-004)
National Institute of Environmental Health Sciences
Application Receipt Date(s):
June 20, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed)
(RFA-MD-18-006)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Application Receipt Date(s):
April 16, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (U01 Clinical Trial Not Allowed)
(RFA-NS-18-015)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s):
April 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)
(RFA-NS-18-024)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s):
April 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
NIDA Small Research Grant Program (R03 Clinical Trial Required)
(PA-18-634)
National Institute on Drug Abuse
Application Receipt Date(s):
Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
(PA-18-642)
National Institute of Mental Health
Application Receipt Date(s):
NIMH accepts and reviews applications on a continuous basis until April 1 of each fiscal year. Applications received after April 1 will be considered for funding in the next fiscal year. Earlier submission is strongly encouraged.
Applications for FY 18 funds should be submitted no later than April 1, 2018.
Applications for FY 19 funds should be submitted no later than April 1, 2019.
Applications for FY 20 funds should be submitted no later than April 1, 2020
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
(PA-18-648)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Office of the Director, NIH
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
(PAR-18-630)
National Institute of Allergy and Infectious Diseases
National Institute on Aging
Application Receipt Date(s):
New Dates April 10, 2018; December 7, 2018; March 7, 2019; December 7, 2019; March 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
(PAR-18-633)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019; September 13, 2019; January 13, 2020; May 13, 2020; September 14, 2020; January 13, 2021), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)
(PAR-18-638)
National Cancer Institute
Application Receipt Date(s):
June 13, 2018; October 11, 2018, June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)
(PAR-18-639)
National Cancer Institute
Application Receipt Date(s):
June 13, 2018; October 11, 2018, June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)
(PAR-18-640)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s):
May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)
(PAR-18-641)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s):
May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional)
(PAR-18-643)
National Heart, Lung, and Blood Institute
Application Receipt Date(s):
April 30, 2018, August 24, 2018, December 18, 2018, April 30, 2019, August 24, 2019, December 18, 2019, April 30, 2020, August 24, 2020, and December 18, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)
(PAR-18-644)
National Institute on Aging
National Cancer Institute
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for resubmission and revision applications is March 16, 2018. The first standard due date for new applications is June 16, 2018.
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)
(PAR-18-645)
National Institute on Aging
National Cancer Institute
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for resubmission and revision applications is March 16, 2018. The first standard due date for new applications is June 16, 2018.
Opportunities for Collaborative Research at the NIH Clinical Center (U01 - Clinical Trial Optional)
(PAR-18-646) Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Dietary Supplements
Office of Research on Women's Health
Application Receipt Date(s):
April 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Human-Animal Interaction (HAI) Research (R03 - Clinical Trial Optional)
(PAR-18-649) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s):
March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Human-Animal Interaction (HAI) Research (R21 - Clinical Trial Optional)
(PAR-18-650) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s):
March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.